Compare Medtronic PLC (MDT) vs ProShares UltraPro Short QQQ ETF (SQQQ) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Medtronic PLC vs ProShares UltraPro Short QQQ ETF — how do they compare? Medtronic PLC trades at $88.48 (market cap $112.24B), while ProShares UltraPro Short QQQ ETF trades at $32.95 (market cap $2.23B). The key difference: Medtronic PLC is far larger — about 50.3× ProShares UltraPro Short QQQ ETF's market cap, and Medtronic PLC pays a 3.28% dividend while ProShares UltraPro Short QQQ ETF pays none. Which is the better fit depends on your goals — on Pluang, investors hold Medtronic PLC for 63 Days and ProShares UltraPro Short QQQ ETF for 12 Days on average.
| MDT | SQQQ | |
|---|---|---|
Market Cap | $112.24B | $2.23B |
Volume | 105,663,236 | 60,436,012 |
Sector | Health | Leveraged / Inverse |
52-Week High | $105.35 | $89.43 |
52-Week Low | $73.75 | $31.83 |
Typical Hold Time | 63 Days | 12 Days |
Enterprise Value | $131.58B | — |
Dividend Yield | 3.28% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Medtronic (MDT) trades at $87.75, up 2.62% today, with strong fundamental performance including three consecutive quarterly earnings beats and a 49-year dividend growth streak. The stock shows bearish technical signals but maintains solid profitability with 13.93% net margins and positive cash flow trends. Recent regulatory approvals for medical devices and raised guidance signal operational momentum despite mixed technical indicators.
Outlook remains positive with analyst consensus at $97.80 (11% upside) and no sell ratings, though technical weakness and increasing debt-to-asset ratios pose near-term risks. The 3.2% dividend yield provides income support while revenue growth acceleration to $37.5B projected for 2026 offers growth potential.
SQQQ (ProShares UltraPro Short QQQ) is trading at $33.37, up 4.02% today amid bearish technical signals. The ETF shows strong bearish momentum with moving averages indicating sell pressure while oscillators remain neutral. Recent news highlights SQQQ's role as a hedging tool against Nasdaq 100 declines, with financial media noting its strategic use during tech sector volatility.
The outlook remains tied to Nasdaq 100 performance, with SQQQ positioned to benefit from further tech weakness. Key risks include timing sensitivity and decay from daily rebalancing. Investment opportunity exists for tactical hedging but requires careful risk management due to the leveraged inverse structure.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Medtronic PLC
One of the largest medical device companies, Medtronic develops and manufactures therapeutic medical devices for chronic diseases. Its portfolio includes pacemakers, defibrillators, heart valves, stents, insulin pumps, spinal fixation devices, neurovascular products, advanced energy, and surgical tools. The company markets its products to healthcare institutions and physicians in the United States and overseas. Foreign sales account for almost 50% of the company's total sales.
Read more on MDT →About ProShares UltraPro Short QQQ ETF
SQQQ is a leveraged inverse ETF that seeks daily investment results, before fees and expenses, that correspond to three times the inverse (-3x) of the daily performance of the Nasdaq-100 Index. It is a tactical trading tool designed for sophisticated investors to profit from or hedge against declines in large-cap technology and growth stocks. Due to its daily reset and the effects of compounding, it is intended for short-term use and carries significant risk if held during periods of high market volatility.
Read more on SQQQ →
